创新药，大跌

Market Overview - On September 11, the Shanghai Composite Index opened down 0.16%, while the ChiNext Index rose by 0.46% [1] - Pharmaceutical stocks experienced significant declines, with companies like BeiGene, WuXi AppTec, and Tigermed opening down over 7% [1] - Over 4,400 stocks were down, with innovative drug concept stocks like BeiGene and Tigermed seeing declines exceeding 10% [1] Index Performance - The Sci-Tech 50 Index stood at 1247.69, down 0.91% [3] - The ChiNext Index was at 2907.80, up 0.12% [3] - The CSI 300 Index was at 4432.68, down 0.29% [3] - The total number of stocks that declined in the Wande All A Index was 4456, while 870 stocks rose [3] Pharmaceutical Sector Performance - The innovative drug index fell by 4.08%, with a net outflow of 17.83 billion [4] - Major pharmaceutical companies like BeiGene and Tigermed saw declines of 10.57% and 10.68%, respectively [5][6] - Other pharmaceutical indices, such as monoclonal antibody and generic drug indices, also reported declines of 4.05% and 3.71% [4] Notable Stock Movements - BeiGene (688235) traded at 283.50, down 10.57% with a market cap of 12.604 billion [5] - Tigermed (300347) traded at 57.36, down 10.68% with a market cap of 147.2 billion [6] - Kanglong Chemical (300759) traded at 30.36, down 7.72% with a market cap of 50%Z [7] Additional Pharmaceutical Stocks - Other notable declines included companies like Aopumai, Bidu Pharmaceutical, and Kailai Ying, with declines ranging from 5.91% to 6.30% [9]